» Articles » PMID: 12676952

The Pro-apoptotic Ras Effector Nore1 May Serve As a Ras-regulated Tumor Suppressor in the Lung

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Apr 5
PMID 12676952
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Ras oncoproteins mediate multiple biological effects by activating multiple effectors. Classically, Ras activation has been associated with enhanced cellular growth and transformation. However, activated forms of Ras may also inhibit growth by inducing senescence, apoptosis, and differentiation. Induction of apoptosis by Ras may be mediated by its effector RASSF1, which appears to function as a tumor suppressor. We now show that the Ras effector Nore1, which is structurally related to RASSF1, can also mediate a Ras-dependent apoptosis. Moreover, an analysis of Nore1 protein expression showed that it is frequently down-regulated in lung tumor cell lines and primary lung tumors. Like RASSF1, this correlates with methylation of the Nore1 promoter rather than gene deletion. Finally, re-introduction of Nore1, driven by its own promoter, impairs the growth in soft agar of a human lung tumor cell line. Consequently, we propose that the Ras effector Nore1 is a member of a family of Ras effector/tumor suppressors that includes RASSF1.

Citing Articles

BRCA1 and NORE1A Form a Her2/Ras Regulated Tumor Suppressor Complex Modulating Senescence.

Nelson N, Jigo R, Clark G Cancers (Basel). 2023; 15(16).

PMID: 37627161 PMC: 10452424. DOI: 10.3390/cancers15164133.


Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.

Williams O, Hu L, Huang W, Patel P, Bartom E, Bei L J Biol Chem. 2023; 299(7):104867.

PMID: 37247756 PMC: 10404618. DOI: 10.1016/j.jbc.2023.104867.


Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.

Salla M, Guo J, Joshi H, Gordon M, Dooky H, Lai J Int J Mol Sci. 2023; 24(6).

PMID: 36983040 PMC: 10055751. DOI: 10.3390/ijms24065967.


RASSF4 inhibits cell proliferation and increases drug sensitivity in colorectal cancer through YAP/Bcl-2 pathway.

Han Y, Zhang X, Guan M, Huo C, Yu C, Hu B J Cell Mol Med. 2022; 26(12):3538-3547.

PMID: 35611809 PMC: 9189339. DOI: 10.1111/jcmm.17395.


In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions.

Hossain M, Roy A, Islam M Sci Rep. 2020; 10(1):14542.

PMID: 32884013 PMC: 7471297. DOI: 10.1038/s41598-020-71457-1.